Skip to main content
. 2019 Dec 6;7(23):3990–4003. doi: 10.12998/wjcc.v7.i23.3990

Figure 2.

Figure 2

One third of colorectal cancer specimens (14/45 cases) show triple positivity for ARSA/ARSB/maspin and low circulating ARSB gene expression level (A), as independent negative prognostic factor (B); the overall survival also depends on independently evaluation of protein tissue level of ARSA (C), ARSB (D) and maspin (E).